• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.03% Nasdaq Up0.29%

    Enanta Pharmaceuticals, Inc. (ENTA)

    -NasdaqGS
    43.94 0.98(2.18%) Jan 26, 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Sep 30, 2013Sep 30, 2012
    Total Revenue 47,741   32,053   41,706  
    Cost of Revenue -   -   -  
    Gross Profit 47,741   32,053   41,706  
    Operating Expenses
    Research Development18,740  16,841  15,115  
    Selling General and Administrative10,016  6,183  5,302  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 18,985   9,029   21,289  
    Income from Continuing Operations
    Total Other Income/Expenses Net301  629  110  
    Earnings Before Interest And Taxes19,286  9,658  21,399  
    Interest Expense18  31   -  
    Income Before Tax19,268  9,627  21,399  
    Income Tax Expense(15,170) -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops34,438  9,627  21,399  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 34,438   9,627   21,399  
    Preferred Stock And Other Adjustments -  (16,196)(20,030)
    Net Income Applicable To Common Shares 34,438   (6,569) 1,369  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.